Stocks · US
MRK
XNYS
Merck & Co., Inc.
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E108.50x
P/B8.21x
P/S5.17x
EPS$1.29
ROE7.57%
ROA2.44%
Dividend yield2.41%
EV/EBITDA28.56x
Debt/Equity1.29
Free cash flow$16.1B
Returns and 52-week range
1W-4.92%
1M-5.58%
3M+12.66%
6M+19.00%
1Y+59.14%
YTD+33.34%
52W high$156.92
52W low$82.01
From 52W high-9.55%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 애브비 | $469.6B | 74.66 | — | +3.99% |
| 유나이티드헬스 그룹 | $339.8B | 24.06 | 3.45 | -5.24% |
| 존슨 앤드 존슨 | $609.5B | 28.97 | 7.17 | -7.43% |
| 노바티스(ADR) | $267.9B | 39.64 | 3.70 | -12.00% |
| 써모 피셔 사이언티픽 | $250.2B | 35.92 | 4.75 | +6.97% |
| 아스트라제네카 | $242.8B | 109.30 | 17.94 | -2.51% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.